Abiopharma

🔍 Tirman Matthew (Executive)

Company: Satellogic Inc. (SATL)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 16,361 shares of Class A Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 156,246.00 | transaction_form_type: 4
• Acquired 7,437 shares of Class A Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 163,683.00 | transaction_form_type: 4
• Sold 23,303 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 186,420.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 10,593 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 137,713.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: On Junes 7, 2024, Mr. Tirman was granted 372,841 RSUs. These RSUs vest in equal quarterly installments from June 20, 2024 through March 20, 2028, generally subject to continued employment through each vesting date. On March 20, 2026, 23,303 shares vested of which 6,942 shares were withheld in order to satisfy Mr. Tirman's obligations for payment of withholding and other taxes due in connection therewith.
• F2: On June 23, 2025, Mr. Tirman was granted 169,492 RSUs. These RSUs vest in equal quarterly installments from June 23, 2025 through June 20, 2029, generally subject to continued employment through each vesting date. On March 20, 2026, 10,593 shares vested of which 3,156 shares were withheld in order to satisfy Mr. Tirman's obligations for payment of withholding and other taxes due in connection therewith.